Jason Loveridge

Jason Loveridge has been managing 4SC AG since September 2016 as CEO. In total, he has over 20 years of international experience in Europe, Asia and the US managing life sciences companies and as a professional investor in privately held and publicly traded companies. In addition, Jason Loveridge has valuable experience in transactions such as the sale or partnering of biotechnology assets. Jason Loveridge studied biochemistry and microbiology at the University of New South Wales, Australia, and holds a PhD in biochemistry from the University of Adelaide, Australia.